Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Other neoplasm 1Breast 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1

Interventions

Selenium 4Epoetin Alfa 3Vitamin E 2Darbepoetin alfa 2Aminolevulinic Acid 2venetoclax 1tirbanibulin 1human papillomavirus vaccine, L1 type 16, 18 1fludarabine 1ferrous sulfate 1ferric gluconate 1camrelizumab 1alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Toremifene 1Surveys and Questionnaires 1Sulindac 1Sucrose 1Soybean Proteins 1Rosuvastatin Calcium 1Ropivacaine 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Propofol 1Polymerase Chain Reaction 1Oxycodone 1Ondansetron 1Morphine 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Soybean Proteins × Other neoplasm × Clear all
NCT00064194 2020-04-03

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Canadian Cancer Trials Group

Phase 3 Completed
310 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡